在肝癌中,NEAT1诱导的CD24从巨细胞中逃离免疫
Hiroyuki Tsuchiya1, Takehiko Hanaki2,3, Tomohiko Sakabe4
1Division of Regenerative Medicine and Therapeutics, Department of Genomic Medicine and Regenerative Therapy, Faculty of Medicine, Tottori University, Yonago, Japan. tsuchiyah@tottori-u.ac.jp.
Oncogene
|August 12, 2025
概括
长非编码RNANEAT1v1通过对巨细胞的CD24进行上调来促进肝细胞癌 (HCC) 免疫逃避. 抑制NEAT1v1和CD24可能会增强HCC患者的抗PD-1治疗.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 分子生物学分子生物学
背景情况:
- 免疫检查点抑制剂 (ICI) 在肝细胞癌 (HCC) 中显示出有限的疗效.
- 像巨细胞一样,免疫抑制细胞有助于HCC的ICI耐药性.
- 长非编码RNAs (lncRNAs) 在癌症进展和免疫调节中发挥作用.
研究的目的:
- 研究长非编码RNA NEAT1 的作用,特别是其短异型NEAT1v1 在HCC免疫逃避中的作用.
- 阐明NEAT1v1影响巨细胞功能和HCC进展的分子机制.
- 评估NEAT1v1作为HCC的潜在治疗点.
主要方法:
- 在巨细胞中研究了NEAT1v1介导的CD24表达的诱导.
- 利用了涉及miR-320a-3p海绵和SP1转录因子激活的机制研究.
- 进行了球形共同培养测定与HCC细胞和巨细胞.
- 评估了巨细胞极化 (M1/M2标记物) 和细胞活性.
- 在用抗PD-1和抗CD24抗体治疗的同源性HCC小鼠模型中评估瘤生长和免疫反应.
- 分析了HCC患者瘤组织和血中NEAT1,SP1,CD24和miR-320a-3p的表达.
主要成果:
- NEAT1v1通过海绵化miR-320a-3p和上调SP1.1来诱导巨细胞上的CD24表达.
- NEAT1v1抑制M1巨细胞标记物和细胞活动,促进一种M2类型的表型.
- 在HCC模型中,NEAT1v1赋予抗PD-1治疗的耐药性.
- 联合抗PD-1和抗CD24抗体治疗显著抑制HCC瘤的生长.
- 在HCC组织中,NEAT1,SP1和CD24是上调的,而miR-320a-3p是下调的;在治疗后,血NEAT1水平下降.
结论:
- NEAT1v1通过 CD24 诱导巨细胞上的"不要吃我"信号来促进 HCC 免疫逃避.
- NEAT1v1代表了一种有前途的治疗标,用于提高HCC的免疫治疗疗效.
- NEAT1v1作为HCC的潜在诊断生物标志物.
相关概念视频
Metastasis
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Cancer Stem Cells and Tumor Maintenance
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cells of the Innate Immune Response
The innate immune response is an immediate and non-specific response against pathogens, acting swiftly to prevent the spread of infections. The primary cells involved in this response are phagocytes and natural killer (NK) cells.
Phagocytes
Phagocytes police the peripheral tissues by removing cellular debris and responding to the invasion of foreign substances or pathogens. Many phagocytes attack and remove microorganisms even before lymphocytes detect them. The human body has two general...
Phagocytes
Phagocytes police the peripheral tissues by removing cellular debris and responding to the invasion of foreign substances or pathogens. Many phagocytes attack and remove microorganisms even before lymphocytes detect them. The human body has two general...
Cytotoxic T Cells-mediated Immune Response
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...


